At Mammotome, we are committed to providing innovative technology to help clinicians accurately diagnose breast cancer, never forgetting that at the core of every diagnosis is the patient. We believe that an accurate diagnosis starts with the right tissue. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. Our comprehensive portfolio includes Mammotome breast biopsy devices, tissue markers, the Neoprobe® Gamma Detection System as well as distribution of the Sirius Medical Pintuition® Localization System for radiation-free sentinel lymph node biopsy.

For more information, visit mammotome.com and follow us on Facebook, LinkedIn, and X.